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Abstract
Endoplasmic reticulum (ER) stress is suggested to play a key role in the pathogenesis of neurodegenerative diseases
including Alzheimer’s disease (AD). Sustained ER stress leads to activation of the growth arrest and leucine zipper
transcription factor, DNA damage inducible gene 153 (gadd153; also called CHOP). Activated gadd153 can generate
oxidative damage and reactive oxygen species (ROS), increase b-amyloid (Ab) levels, disturb iron homeostasis and induce
inflammation as well as cell death, which are all pathological hallmarks of AD. Epidemiological and laboratory studies
suggest that cholesterol dyshomeostasis contributes to the pathogenesis of AD. We have previously shown that the
cholesterol oxidized metabolite 27-hydroxycholesterol (27-OHC) triggers AD-like pathology in organotypic slices. However,
the extent to which gadd153 mediates 27-OHC effects has not been determined. We silenced gadd153 gene with siRNA and
determined the effects of 27-OHC on AD hallmarks in organotypic slices from adult rabbit hippocampus. siRNA to gadd153
reduced 27-OHC-induced Ab production by mechanisms involving reduction in levels of b-amyloid precursor protein (APP)
and b-secretase (BACE1), the enzyme that initiates cleavage of APP to yield Ab peptides. Additionally, 27-OHC-induced tau
phosphorylation, ROS generation, TNF-a activation, and iron and apoptosis-regulatory protein levels alteration were also
markedly reduced by siRNA to gadd153. These data suggest that ER stress-mediated gadd153 activation plays a central role
in the triggering of AD pathological hallmarks that result from incubation of hippocampal slices with 27-OHC. Our results
add important insights into cellular mechanisms that underlie the potential contribution of cholesterol metabolism in AD
pathology, and suggest that preventing gadd153 activation protects against AD related to cholesterol oxidized products.
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Introduction
Alzheimer’s disease (AD), the most common neurodegenerative
disorder,is histopathologically characterizedby the accumulationof
b-amyloid (Ab) peptide and the hyperphosphorylation of tau
protein. In addition to increased levels of Ab and phosphorylated
tau, oxidative stress, inflammation, and cell death contribute to the
neurodegenerative features of AD [1]. Accumulation of Ab peptides
in soluble and insoluble forms is suggested to be the trigger of the
neurodegenerative processes that lead to the development of AD.
Currently, there is no consensus as to what are the factors or cellular
mechanisms that lead to Ab accumulation in the brain. We have
shown that cholesterol-enriched diets increase Ab production and
oxidative damage involving the activation of the growth and arrest
DNA damage protein gadd153 [2]. Gadd153 (also called CHOP) is
activated by endoplasmic reticulum (ER) stress and can cause
cellular damage by mechanisms that include induction of oxidative
stress, generation of reactive oxygen species (ROS), triggering of
apoptosis, and disturbing iron homeostasis [3–5]. The ability of
gadd153 to increase ROS generation can lead to increased
production of b-secretase (BACE1), the rate limiting enzyme that
cleaves b-APP to yield Ab, thus leading to increased Ab levels [6,7].
ER stress-induced gadd153 activation may thus triggers AD-like
pathology by generating oxidative damage and increasing Ab
production. Silencing gadd153 gene expression would therefore
represent a potential strategy to reduce ROS generation, BACE1
activation, and Ab accumulationand ultimately protect against AD.
We have recently shown that the cholesterol oxidized
metabolite (oxysterol) 27-hydroxycholesterol (27-OHC) causes
AD-like pathology in human neuroblastoma cells and in
organotypic slices from adult rabbit hippocampus [8–10]. In this
study, we incubated organotypic slices from adult rabbit
hippocampus with 27-OHC, in the presence or absence of siRNA
to gadd153, and determined the effects on levels of Ab,
phosphorylated tau, ROS, oxidative and ER stress, iron
homeostasis and apoptosis-regulatory proteins, which are all
relevant to AD pathology. The organotypic slice system has many
advantages in that connectivity between neurons, interneurons
and glia is maintained. In addition, rabbits have a phylogeny
closer to humans than rodents [11], and their Ab sequence, unlike
that of rodents, is similar to the Ab sequence of the human [12].
We found that siRNA to gadd153 dramatically reduces the
generation of a wide range of events that are relevant to AD.
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Preparation of organotypic slices and treatments
Organotypic slices were prepared as we have previously shown
[8,10]. In brief, hippocampi from adult male rabbits (n=4; 1.5–2
year old) were dissected and sectioned with a MacIlwain chopper
(300 mm thick). Each hippocampus yields about 60 sections (120
sections per rabbit). Five sections were plated on membrane inserts
(Millipore, Bedford, MD), with a total of 12 inserts per
hippocampus (24 inserts per rabbit). Inserts were placed in
35 mm culture dishes containing 1.1 ml growth media (Neuroba-
sal A with 20% horse serum, 0.5 mM l-glutamine, 100 U/ml
penicillin, and 0.05 mM/ml streptomycin). Slices were exposed to
a humidified incubator atmosphere (4.5% CO2 and 35uC). Media
was changed at day 1, and at day 4 slices were switched to a
defined medium consisting of Neurobasal A, 2% B27 supplement
and 0.5 mM l-glutamine. At day 8, slices were divided to 4 groups
(twenty four dishes of five slice each per group) as the following:
Control slices, 27-OHC-treated slices, gadd153 siRNA-treated
slices, and gadd153 siRNA+27-OHC-treated slices. All animal
procedures were carried out in accordance with the U.S. Public
Health Service Policy on the Humane Care and Use of
Laboratory Animals and were approved by the Institutional
Animal Care and Use Committee at the University of North
Dakota (protocol number 1101-1C).
siRNA to gadd153/CHOP and non silencing control siRNA
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
The following human gadd153 gene sequences (59R39 orienta-
tion) were used (A): Sense GAAGGCUUGGAGUAGACAAtt,
Antisense UUGUCUACUCCAAGCCUUCtt; (B): Sense GGA-
AAGGUCUCAGCUUGUAtt, Antisense UACAAGCUGAGAC-
CUUUCCtt; (C): Sense GUCUCAGCUUGUAUAUAGAtt,
Antisense UCUAUAUACAAGCUGAGACtt. The transfection of
siRNA was performed in the slices with siRNA transfection
reagent (Santa Cruz Biotechnology) and siRNA transfection
medium (Santa Cruz Biotechnology) according to the manufac-
turer’s recommendation on day 8. The siRNAs (final concentra-
tion, 200 nM) were mixed with 100 ml of siRNA transfection
medium. This mixture was gently added to a solution containing
20 ml of siRNA transfection reagent in 100 ml of siRNA
transfection medium. The mixture solutions were incubated for
45 minutes at room temperature and 800 ml of siRNA transfection
medium was added to the solution. Half of the final solution was
added to the bottom of the inserts and remaining half onto the top
of the slices with total of 1 ml in each dish. Transfected slices were
incubated at 37uC for 48 hours without changing medium and
then, treated with either 25 mM of 27-OHC (Medical Isotopes,
Pelham, NH) or vehicle (0.1% ethanol). After 72 hours of
treatment, samples were collected for ELISA, Western blot, real-
time RT-PCR, reactive oxygen species, hydrogen peroxide,
isoprostane, glutathione levels and confocal microscopy studies.
Quantification of secreted Ab and TNF-a levels by ELISA
Ab levels were quantified in the media of treated organotypic
slices by ELISA using a kit from Invitrogen (Carlsbad, CA) as per
the manufacturer’s protocol. Briefly, following treatments, the
culture medium was collected, supplemented with protease and
phosphatase inhibitor cocktail, and centrifuged at 16,0006 g for
5 min at 4uC. 100 ml of supernatant was used for Ab40 and Ab42
quantification. The quantity of Ab in each sample was measured
in duplicate and expressed as mean 6 standard error for the
samples. Ab40 and Ab42 levels are expressed in pg/ml.
TNF-a released in media was quantified using a colorimetric
sandwich human TNF-a ELISA (Invitrogen, Camarillo, CA)
according to the manufacturer’s protocol. Treatments were
performed in triplicate, and the quantity of TNF-a in each sample
was measured in duplicate and expressed as mean 6 standard
error for the samples. TNF-a levels are expressed in pg/ml.
Western blot analysis
Organotypic slices were homogenized with the tissue protein
extraction reagent (T-PER, Thermo Scientific, Rockford, IL)
supplemented with protease and phosphatase inhibitors. Protein
concentrations were determined with the BCA protein assay
reagent by standard protocol. Proteins (10 mg) were separated in
10% and 12.5% SDS-PAGE gels, transferred to a polyvinylidene
difluoride membrane (Millipore) and incubated with antibodies to
APP (1:100, Chemicon International, Temecula, CA), BACE1
(1:100, Chemicon International), phosphorylated tau (PHF-1 and
CP13, 1:500, gift from Dr. Peter Davis, Albert Einstein College of
Medicine), total tau (1:200, Calbiochem, La Jolla, CA), to the
apoptosis-regulatory proteins Bax (1:100, Santa Cruz Biotechnol-
ogy), caspase 3 (1:100, Santa Cruz Biotechnology) and Bcl-2
(1:100, Santa Cruz Biotechnology), to the ER- glucose regulated
proteins grp 78 (1:100, Assay Designs Stressgen, Ann Arbor, MI)
and grp 94 (1:100, Affinity Bioreagents, Golden, CO), to the ER-
stress marker gadd153 (1:100, Abcam, Cambridge, MA), to the
iron regulatory proteins transferrin receptor (TfR, 1:100, Abcam),
ferritin light chain (FLC, 1:100, Santa Cruz Biotechnology),
ferritin heavy chain (FHC, 1:100, Santa Cruz Biotechnology), and
iron regulatory proteins-1 and 2 (IRP-1, 1:500, Millipore; IRP-2,
1:100, Chemicon International), and to the inflammation marker
Tumor necrosis factor (TNF-a, 1:100, Abcam). b-actin (1:5000)
was used as a gel loading control. The blots were developed with
enhanced chemiluminiscence (Immun-star HRP chemiluminiscent
kit, Biorad, Herculus, CA). The results were quantified by
densitometry and represented as total integrated densitometric
values.
Real-time reverse transcriptase polymerase chain
reaction (real-time RT-PCR)
Total RNA was isolated and extracted from organotypic slices
using the 5 prime PerfectPure RNA tissue kit (5 Prime, Inc.,
Gaithersburg, MD) as we have previously described [8]. 1 mgo f
purified RNA was converted to cDNA by using qScript CDNA
SuperMix (Quanta Biosciences, Gaithersburg, MD). The cDNA
was amplified using PerfeCTa SYBR Green FastMix for iQ (2X,
Quanta Biosciences) in Bio-Rad iCycler iQ Multicolor Real Time
PCR Detection System (BioRad, Hercules, CA). Primers for gene
of interest and the housekeeping gene glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) were designed with Beacon Designer
4.0. The primer sequences (forward; reverse, both in the 59 to 39
direction) are: Gadd153 (TGCTTCTCTGGCTTGGCTGAC;
CTGGTTCTCCCTTGGTCTTCC), TNF-a (CGCTTCGCC-
GTCTCCTACC; GGCAAGGTCCAGGTACTCAGG), and G-
APDH (AGGTCATCCACGACCACTTC; GTGAGTTTCC-
CGTTCAGCTC). The amplification process time was 15 min
at 95uC followed by 80 cycles of 30 s at 95uC, 1 min at 55uC and
30 s at 72uC. Values were expressed in cycle threshold time (Ct)
and were normalized to the Ct times for the housekeeping gene
GAPDH. Primer specificity was confirmed by a single peak in a
dissociation curve and/or by a single band following gel
electrophoresis of the primer products.
RNA band shift assay
The IRP-IRE interactions were performed using LightShift
Chemiluminescent RNA Electrophoretic mobility shift assay kit
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ferritin light chain iron regulatory element (IRE) probe UCUUG-
CUUCAACAGUGUUUGAACGGAAC was biotin labeled (Sig-
ma, St. Louis, MO) at 39.1 0 mg of cytoplasmic protein of
organotypic slices following treatments was incubated with 2 nM
(final concentration) of biotin labeled IRE probe in binding buffer
provided in the kit following manufacturer’s protocol. 5 ml of IRP-
IRE complexes formed were resolved on 5% DNA retardation gel
(Biorad) and transferred on to nylon membrane (Roche Diagnos-
tics, Indianapolis, IN). After the membrane was cross linked with
UV-light, the IRP-IRE complexes were visualized with enhanced
chemiluminiscence (Immun-star HRP chemiluminiscent kit,
Biorad, Herculus, CA) according to the manufacturer’s protocol.
Electrophoretic mobility shift experiments were performed at least
three times and one representative experiment was shown.
Reactive Oxygen Species (ROS) Assay
ROS generation was determined using 29–79-dichlorofluores-
cein-diacetate (DCFH-DA) and fluorometric detection of H2O2 as
we have previously described [13]. For DCFH-DA measurements,
25 mg of homogenate from control and treated organotypic slices
were diluted in PBS and incubated with 5.0 mM DCFH-DA
(Sigma, St. Louis, MO) in the dark for 15 minutes at 37uC.
Fluorescence was measured every 15 minutes for 1 hr with
excitation and emission wavelengths of 488 nm and 525 nm
respectively, using a Spectramax Gemini-EM (Molecular Probes,
Sunnyvale, CA). Values are expressed as percent increase in
fluorescence compared to controls. H2O2 was measured using the
horseradish peroxidase (HRP)-linked fluorometric assay (Amplex
Ultra Red; Invitrogen, Carlsbad, CA) following the manufacturer’s
recommendation and as we described previously [13]. Resorufin
fluorescence was followed by a Spectramax Gemini-EM (Molec-
ular Probes, Sunnyvale, CA) with excitation 530–560 nm and
emission at 590 nm.
Oxidative stress measurements
Isoprostanes and glutathione depletion assays were used to
measure oxidative stress levels. The F2-isoprostane 8-Iso-prosta-
glandin F2a (8-iso-PGF2a) is produced by lipid peroxidation and is
a marker of oxidative stress. 8-iso-PGF2a levels were quantified in
the control and treated organotypic slices using the isoprostane
oxidative stress assay kit B (Biomol International, Plymouth
Meeting, PA) as we have shown previously [13]. The color
developed in the standards and samples was read on a SpectraMax
Plus microplate reader (Molecular Devices, Sunnyvale, CA) at
405 nm. The measured optical density was used to calculate the
concentration of 8-iso-PGF2a. Glutathione (gamma-glutamyl-
cysteinyl-glycine; GSH) plays an important role in antioxidant
defense in animal cells. Increased levels of oxidative stress lead to
the accumulation of oxidized glutathione (GSSG) and a subse-
quent decrease in the ratio of reduced glutathione (GSH) to
GSSG. A luminescent based GSH-Glo Assay (Promega Corpora-
tion, Madison, WI) was used for quantification of glutathione
according to the manufacturer’s recommendation and as we have
previously reported [13].
Confocal microscopy
Alterations in total intracellular iron distribution were deter-
mined using the fluorescent indicator Phen-green SK, the
fluorescence of which is quenched by iron. Organotypic slices
were incubated with phen green SK (20 mM of the diacetate) [14]
for 1 hour at 37uC. The slices were mounted with vectasheild
containing DAPI (Vector laboratories, Inc., Burlingame, CA).
Phen-green SK staining was visualized with a Zeiss LSM 510
META confocal system coupled to a Zeiss Axiophot 200 inverted
epifluorescence microscope. Imaging was performed with a 406
oil immersion objective.
Statistical Analysis
Data was analyzed for statistical significance using one-way
analysis of variance (ANOVA) followed by Newman-Keuls
Multiple Comparison Test with GraphPad Prism software 4.01.
All values in each group were expressed as mean value 6 SEM.
All group comparisons were considered significant at p,0.05.
Results
Silencing gadd153 with siRNA reversed 27-OHC-induced
increase in gadd153 levels
Western blot and densitometric analysis (Fig. 1a,b) show that
treatment with 27-OHC induced a substantial increase in gadd153
levels in comparison to control levels in hippocampal slices.
Treatment with siRNA to gadd153 completely suppressed basal
gadd153 levels and markedly reduced the 27-OHC-induced
increase in gadd153 levels. Real-time RT-PCR demonstrated that
27-OHC also increases gadd153 mRNA and that treatment with
siRNA to gadd153 reduces the basal as well as the 27-OHC-
induced increase in gadd153 mRNA (Fig. 1c). Treatment of slices
with siRNA to gadd153 reduced both the basal distribution of
gadd153 and the large increase induced by 27-OHC treatment.
Western blot and real-time RT-PCR demonstrate the efficiency of
gadd153 silencing.
Our results also show that the 27-OHC increased the levels of
the ER-resident chaperone proteins grp 78 and grp 94 in
organotypic slices (Fig. 1d–f). Treatment of slices with siRNA to
gadd153 didn’t affect levels of grp 78 or grp 94 in slices untreated
with 27-OHC but significantly reduced levels of these chaperones
in slices treated with 27-OHC. Together, with increased gadd153,
the increase in grp 78 and grp 94 levels demonstrates that 27-
OHC targets the ER and causes stress in this organelle.
siRNA to gadd153 reduced 27-OHC-induced increase in
Ab levels
Treatment with 27-OHC led to an increase in secreted levels of
both Ab40 and Ab42 in media of the organotypic slices as
determined with ELISA assay (Fig. 2a,b). While levels of Ab40
increased from 24.0560.79 in media of control slices to
31.3161.11 pg/ml in media of 27-OHC-treated slices, levels of
Ab42 were 4.4960.59 pg/ml in media of control slices and
7.2660.55 pg/ml in media of 27-OHC treated organotypic
samples. In media of slices treated with siRNA to gadd153 alone,
levels of Ab40 and Ab42 were decreased by 45% and 52%
respectively compared to control levels. siRNA to gadd153 also
reduced levels of Ab40 and Ab42 by 36% and 54% in slices
treated with 27-OHC compared to slices treated with 27-OHC
alone (Fig. 2a,b). The decrease in Ab levels with siRNA to
gadd153 suggests that gadd153 regulates the production of Ab
from APP by BACE1 enzyme. To confirm the specificity of
siRNA, we performed gadd153 silencing using the three siRNA
probes individually, rather than a mixture of the three. Each of the
three probes markedly reduced gadd153 as well as BACE1 levels
(Supporting Figure S1).
Our results show that the increase in the levels of Ab40 and
Ab42 in the 27-OHC-treated slices was accompanied with an
increase in the levels of parent protein APP as well as of BACE1,
the enzyme that initiates the cleavage of APP to yield Ab (Fig. 2c–
e). Treatment with siRNA to gadd153 alone, while didn’t affect
APP levels, reduced BACE1 levels. Treatment with siRNA to
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BACE1 to control levels. These results suggest that gadd153
regulates Ab production by primarily controlling BACE1 levels.
siRNA to gadd153 reversed 27-OHC-induced
phosphorylation of tau
The phosphorylation of tau protein was determined with PHF-1
and CP13, antibodies that detects tau phosphorylated at Ser396/
404 and Ser202 respectively. Our results show that 27-OHC-
induced about a two-fold increase in phosphoylated tau as
detected by both PHF-1 and CP13 antibodies (Fig. 2 f–h). siRNA
to gadd153 did not affect basal levels of phosphorylated tau but
significantly reduced the increase in tau phosphorylation induced
by 27-OHC. These results suggest that siRNA to gadd153 reduces
tau phosphorylation in conditions where there is an abnormal
increase in the phosphorylation of tau but not in the basal state.
siRNA to gadd153 reduces 27-OHC-induced alteration in
apoptosis-regulatory proteins
A growing body of evidence suggests an active role for the ER in
the regulation of apoptosis by mechanisms that involve regulation
of apoptosis-regulatory protein levels [15]. We determined the
effect of siRNA to gadd153 on levels of Bax, caspase 3 and Bcl-2.
Our data shows that 27-OHC significantly increased level of the
pro-apoptotic proteins Bax and the effector of apoptosis caspase 3
(Fig. 3). While siRNA to gadd153 didn’t affect basal levels of Bax
and caspase 3, it significantly reduced the increase in levels of these
proteins induced by 27-OHC. On the other hand, levels of the
anti-apoptotic protein Bcl-2 were markedly reduced by 27-OHC
treatment and incubation of slices with siRNA to gadd153 in
presence or absence of 27-OHC markedly increased levels of Bcl-2
beyond control levels. These latter results suggest that gadd153
may regulate the basal expression levels of Bcl-2 (Fig. 3).
siRNA to gadd153 protects from 27-OHC-induced
oxidative stress
ER stress is known to induce oxidative stress and oxidative stress
can also cause ER stress [16]. We determined the extent to which
27-OHC-induced ER stress is associated with ROS generation,
isoprostane formation and glutathione depletion, which are all
markers for oxidative stress. Our results show that the 27-OHC
increased levels of ROS, H2O2 and 8-iso-PGF2a, and reduced
levels of glutathione in rabbit hippocampus organotypic slices
(Fig. 4). While treatment with siRNA to gadd153 alone didn’t alter
Figure 1. siRNA to gadd153 reduces 27-OHC-induced alteration in ER protein levels in organotypic slices from rabbit hippocampus.
27-OHC significantly increased protein levels (a,b) as well as mRNA (c) of gadd153 and treatment with siRNA to gadd153 markedly reduced the 27-
OHC-induced increase in expression levels of gadd153. Treatment with siRNA also reduced the increase in levels of the ER chaperones grp 78 and and
grp 94 induced by 27-OHC (d–f). *p,0.05, **p,0.01 and ***p,0.001 versus controls;
#p,0.05 and
###p,0.001 versus 27-OHC.
doi:10.1371/journal.pone.0026420.g001
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27-OHC-induced increase in levels of these oxidative stress
markers. Interestingly, as it was the case with BACE1 and Bcl-2,
treatment with siRNA to gadd153 alone markedly increased
glutathione levels in comparison to levels in control untreated
slices. Additionally, siRNA to gadd153 reversed the depletion of
Figure 2. siRNA to gadd153 reduces 27-OHC-induced increase in Ab production and tau phosphorylation. 27-OHC significantly
increased levels of both secreted Ab40 and Ab42, and treatment with siRNA, alone or in presence of 27-OHC, significantly reduced Ab40 and Ab42
levels (a,b). siRNA to gadd153 also reduced 27-OHC-induced increase in APP and BACE1 levels (c–e). Note that siRNA to gadd153 markedly reduced
basal levels of BACE1, suggesting that gadd153 regulates BACE1 transcription (c,e). Treatment with 27-OHC also increases phosphorylation of tau as
detected with PHF-1 and CP13 antibodies (f–h). The increase in phosphorylated tau is reduced by treatment with siRNA to gadd153. *p,0.05,
**p,0.01 and ***p,0.001 versus controls;
#p,0.05,
##p,0.01 and
###p,0.001 versus 27-OHC.
doi:10.1371/journal.pone.0026420.g002
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show that silencing the expression of gadd153 protects against the
oxidative damage that can be triggered by 27-OHC.
27-OHC altered iron metabolism and increased TNF-a
levels, effects reversed by siRNA to gadd153
Dyshomeostasis of iron metabolism has been suggested to
mediate the neurodegenerative processes that characterize AD
[17–21]. We determined levels of transferrin receptor (TfR) which
regulates iron uptake and ferritin light and heavy chains that
regulate iron storage. While treatment with 27-OHC reduced
levels and expression of TfR, expression levels of ferritin light
chain and ferritin heavy chain were significantly increased in slices
treated with 27-OHC compared to untreated slices (Fig. 5a–d).
Treatment with siRNA to gadd153, alone or in presence of 27-
OHC, increased expression levels of TfR. siRNA to gadd153
significantly increased the 27-OHC-induced decrease in expres-
sion levels of TfR (Fig. 5a,b). On the other hand, 27-OHC
increased expression levels of both ferritin light and heavy chain
(Fig. 5a,c,d). Treatment with siRNA to gadd153 didn’t affect basal
levels of these proteins but reduced the increase in their expression
levels induced by 27-OHC. The decrease in TfR and increase in
ferritin levels resulting from 27-OHC treatment was associated
with cellular accumulation of iron, as evidenced by the intense
staining of phen-green SK, a sensitive fluorescence probe for free
iron (Fig. 5e). The 27-OHC-induced iron accumulation was
reduced with siRNA to gadd153. We also determined protein
levels of the iron-regulatory proteins IRP-1 and IRP-2 that
regulate levels of ferritin post-transcriptionally. Levels of IRP-1
and IRP-2 were significantly decreased with 27-OHC treatment
compared to controls (Fig. 6a–c). Treatment with siRNA to
gadd153 alone didn’t alter levels of these proteins but reversed the
decrease induced by 27-OHC.
REMSA assay (Fig. 6d) shows a clear shift in bands in control as
well as in gadd153 siRNA alone-treated slices indicating the
binding of IRP to IRE. In the contrary, no shift in band was
observed in the slices treated with 27-OHC alone, demonstrating
that 27-OHC inhibits binding of IRP to IRE. A significant band
shift was observed in slices treated with both siRNA to gadd153
and 27-OHC showing that siRNA to gadd153 partially, but
significantly, restores the binding of IRP to IRE.
As activation of TNF-a has been shown to induce the
expression of ferritin in a variety of cell lines [22,23] and thus
can dysregulate iron homeostasis, we determined levels of TNF-a,
which is also a prominent marker of inflammation. Levels of TNF-
a in tissue (a,b) and in media (d) were significantly increased with
27-OHC treatment compared to control levels (Fig. 7). Treatment
with siRNA to gadd153, while didn’t alter basal levels of TNF-a,i t
reduced the 27-OHC-induced increase in TNF-a levels. Real-time
RT-PCR analysis also showed that siRNA to gadd153 reduced 27-
OHC-induced increase in TNF-a expression (Fig. 7c).
Discussion
In the present study we show that treatment of organotypic
slices with the oxysterol 27-OHC causes ER stress as evidenced
with increased levels of the ER-specific proteins gadd153, grp 78
and grp 94. Stress in the ER is associated with increased Ab
production, phosphorylated tau levels, apoptosis, oxidative stress,
and iron dyshomeostasis, which are all pathological hallmarks of
Figure 3. siRNA to gadd153 gene reverses 27-OHC-induced apoptosis. Treatment of slices with 27-OHC while increases levels of the pro-
apoptotic Bax and of the active caspase 3, this treatment reduces levels of the anti-apoptotic Bcl-2 (a–d). siRNA to gadd153 reduces the increase in
Bax as well as caspase 3 levels and markedly increases levels of Bcl-2 in presence or absence of 27-OHC. *p,0.05 and ***p,0.001 versus controls;
#p,0.05,
##p,0.01 and
###p,0.001 versus 27-OHC.
doi:10.1371/journal.pone.0026420.g003
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reduced the generation of the AD hallmarks. Our data strongly
suggest that increased levels of gadd153 plays an important role in
the 27-OHC-induced effects.
Disturbances in ER functions leads to activation of ER stress
response that involves various pathways and proteins (see for
review [24]). Gadd153 is a member of the C/EBP family of bZIP
transcription factors, and is expressed at low levels in normal
conditions and is highly expressed in response to sustained stress in
the ER [3,4,25]. Various transcription factors that activate the
unfolded protein response activate gadd153 gene transcription.
Overexpression of gadd153 has been shown to trigger apoptosis
and to contribute to cell death by downregulating the anti-
apoptotic protein Bcl-2 [4,26]. Gadd153 deficiency protects
against apoptosis in mice [27,28] and cultured macrophages
[29–31]. The mechanisms by which gadd153 induces apoptosis
are not well known but downregulation of the anti-apoptotic
protein Bcl-2 may play an important role [15]. We demonstrate
here that silencing gadd153 gene expression reversed the 27-
OHC-induced reduction in levels of Bcl-2 and increased levels of
the apoptotic proteins Bax and caspase 3. Interestingly, siRNA to
gadd153 increases the basal levels of Bcl-2, suggesting that
gadd153 regulate the transcription of Bcl-2 gene. Previous studies
have also shown that gadd153 sensitizes cells to ER stress by
downregulating Bcl-2 [3] and upregulating Bax [4,26]. It may also
be possible that 27-OHC-induced accumulation of Ab may trigger
apoptosis by mechanisms independent of gadd153 as accumula-
tion of Ab is known to increase cell death by increasing Bax and
decreasing Bcl-2 levels [32–34]. siRNA to gadd153 may reduce
apoptosis indirectly by reducing BACE1 and APP, which are
responsible for Ab production. Whether 27-OHC causes apoptosis
through increased levels of Ab and/or directly by increasing levels
of gadd153 is yet to be elucidated.
In addition to promoting apoptosis, gadd153 can increase ROS
production [3,16,27,35], leading to oxidative damage. Oxidative
damage is considered as an early events in AD [36]. As both ER
stress and oxidative damage are tightly linked and increased levels
of ROS also triggers ER stress [16], the extent to which ER stress
precedes oxidative damage or vice versa is not clear. Increased
levels of ROS are known to enhance the activity of BACE1, the
enzyme that initiates cleavage of b-APP to yield Ab, thereby
causing Ab overproduction [6,7]. Interestingly, we demonstrate
Figure 4. siRNA to gadd153 gene reduces 27-OHC-induced oxidative stress. Silencing gadd153 gene expression reduces 27-OHC-induced
increase in reactive oxygen species (ROS) generation, isoprostane formation and glutathione depletion. ROS generation was measured with increased
fluorescence with the DCFH-DA assay (a), H2O2 levels were measured using Amplex red (b), isoprostane level were detected with formation of 8-iso-
PGF2a (c) and glutathione depletion was assessed with reduction in glutathione (GSH): reduced glutathione (GSSG) ratio (d). *p,0.05, **p,0.01 and
***p,0.001 versus controls;
#p,0.05,
##p,0.01 and
###p,0.001 versus 27-OHC.
doi:10.1371/journal.pone.0026420.g004
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PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e26420Figure 5. siRNA to gadd153 reduces alterations in iron homeostasis caused by 27-OHC. Treatment with 27-OHC reduces transferrin
receptor (TfR) levels and increases levels of ferritin light chain (FLC) as well as ferritin heavy chain (FHC) (a–d). Staining with Phen-green SK, a probe
which the fluorescence of which is quenched by iron, shows an accumulation of iron in slices treated with 27-OHC compared to control slices and
treatment with siRNA to gadd153 reduces the intensity of Phen-green SK staining (e). *p,0.05 and **p,0.01 versus controls;
#p,0.05 versus 27-
OHC.
doi:10.1371/journal.pone.0026420.g005
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enzyme. These results suggest that gadd153 regulates transcription
activity of BACE1. Further studies are needed to determine the
cellular mechanisms by which gadd153 regulate BACE1 expres-
sion. There is evidence that BACE1 expression is transcriptionally
regulated by NF-kB [37] and that gadd153 activated by ER stress
regulates NF-kB signaling [38]. On the other hand, the ER has
been shown to regulate Ab production by controlling the protein
folding for APP and delaying the access for BACE1 to process APP
[39]. Alterations in the ER function subsequently to stress would
lead to alterations in the processing and regulation of Ab levels.
Further studies are needed to determine the cellular mechanisms
by which gadd153 regulate BACE1 expression in our system.
The increase in the levels of isoprostanes and depletion in the
glutathione system foster oxidative stress. Decreased levels of
glutathione (GSH) are a marker for increased free radical levels in
AD [40]. Free radicals increase production of APP, Ab as well as
ROS [41,42]. Our results show that 27-OHC-induced increase in
ROS, isoprostanes and glutathione depletion are greatly reduced
by siRNA to gadd153. Of seminal relevance, siRNA to gadd153
alone increases levels of glutathione to levels higher than basal
levels suggesting, as is the case for Bcl-2 and BACE1, that gadd153
regulates glutathione activity. It has been suggested that gadd153
may interfere with glutathione synthesis by regulating c-glutamyl
cysteine synthase enzyme [3]. Effects of gadd153 on c-glutamy
cysteine synthase enzyme and glutathione synthesis are still to be
investigated.
ER stress is associated with a number of diseases including
neurodegenerative diseases, obesity, and atherosclerosis, [43–46].
Increased levels of gadd153 have been observed in PS-1 transgenic
mice for AD [47]. In addition to increasing levels of gadd153, 27-
OHC increases levels of ER molecular chaperone grp 78 and grp
94. Grp 78 has been shown to bind to b-APP in the ER and to
reduce Ab secretion in human embryonic kidney 293 cells [48].
Grp 78 has also been demonstrated to stimulate Ab42 clearance in
rat mixed glial cell cultures [49]. These results suggest that grp 78
facilitates the correct folding of APP in the ER and that alterations
in grp 78 levels may cause the accumulation of extracellular Ab42
[49]. Regarding grp 94, the expression of this protein has been
found to increase in the parietal cortex of AD patients [50]. We
have found increased levels of both grp 78 and grp 94. While the
significance of increased levels of these proteins to 27-OHC-
induced apoptosis, oxidative stress and Ab accumulation is still to
be elucidated, alterations in these levels is a direct indication of
triggering of ER stress by 27-OHC. Gadd153 gene silencing
reduced the increase in levels of these proteins.
Our results show that 27-OHC also increased phosphorylation
of tau protein, another important hallmark of AD. The exact
mechanism by which gadd153 regulates tau phosphorylation is yet
to be determined. siRNA to gadd153 may reduce levels and
activities of enzymes responsible for phosphorylation of tau. It may
also be possible that reduction in Ab by siRNA to gadd153 reduces
phosphorylation of tau as tau phosphorylation is considered a
downstream event to Ab accumulation [51,52]. Another impor-
tant pathological hallmark observed in AD is disturbances in iron
homeostasis. Iron is an essential element and participate in various
toxic reactions and generate free radicals by Fenton reaction
[2,53,54]. The iron homeostasis in the cells is maintained by
interactions of iron regulatory proteins (IRP), ferritin, transferrin
and transferrin receptor proteins. Ferritin is the iron storage
Figure 6. Reduction in iron-regulatory protein levels by 27-OHC is prevented by siRNA to gadd153. While treatment with 27-OHC
reduces levels of IRP-1 and IRP-2, siRNA to gadd153 reverses the effects of 27-OHC on IRP-1 and IRP-2 levels (a–c). REMSA assay shows a clear shift in
bands resulting from binding of IRP to IRE in control (line 4) as well as in gadd153 siRNA alone- treated slices (line 6). No shift in band was observed in
the slices treated with 27-OHC alone (line 5) demonstrating that 27-OHC inhibits binding of IRP to IRE. Treatment with siRNA to gadd153 in presence
of 27-OHC causes a band shift indicating that siRNA to gadd153 partially, but significantly, restores the binding of IRP to IRE (line 7). Lanes 1–3 –
positive controls; lane 1 - biotin labeled IRE probe, lane 2 - biotin labeled IRE probe+cytosolic liver extract, lane 3 - biotin labeled IRE probe+cytosolic
liver extract+200 fold molar excess of unlabeled IRE RNA. *p,0.05 versus controls;
#p,0.05 versus 27-OHC.
doi:10.1371/journal.pone.0026420.g006
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Transferrin receptor (TfR) is a transmembrane protein that
transports iron into cells and its density is regulated by intracellular
iron levels [56–58]. Transferrin (Tf), with the support of TfR,
mobilizes iron [59,60]. IRPs can sense iron levels in the cell and
regulate the expression of proteins that are involved in iron
metabolism [61–66]. Disruption of iron metabolism has been
suggested to contribute to the pathogenesis of AD and other
neurodegenerative diseases [67]. The iron accumulation we show
with 27-OHC was associated with an increase in ferritin and a
decrease in TfR as well as IRP-2 levels. An increase in level of
ferritin was observed in AD compared to normal [68], varying
depending on the brain regions [18]. Low levels of TfR have been
observed in specific regions in the brain of AD in a study by
Kalaria and colleagues [56]. The increase in the levels of iron with
27-OHC may have resulted from decreased expression of TfR,
both at protein and mRNA levels, as TfR expression is strictly
regulated by the intracellular iron levels and increased iron levels
can lead to degradation of TfR mRNA [69]. Accumulation of
ferritin and dysregulation of iron metabolism were observed in
IRP-2 mutated mice [70] and alterations in the IRP-2 localization
were reported in AD [71]. IRP-IRE binding regulates the iron
levels in the cells. The high levels of iron in slices treated with 27-
OHC is confirmed by REMSA assay that shows no band shift. A
band shift would normally indicate that IRP did not bind to IRE
probe. If the cells are overloaded with iron IRPs does not bind to
IRE and the synthesis of ferritin and degradation of TfR increase.
The increase in the levels of iron induced by 27-OHC can cause or
exacerbate oxidative damage [72,73] and ER stress [74].
Remarkably, siRNA to gadd153 substantially reduced disturbanc-
es in iron dyshomeostasis induced by 27-OHC. Activation of
TNF-a may also potentially dysregulate iron homeostasis.
Alteration in ferritin expression may result from TNF-a activation
and may lead to the release of iron from ferritin stores, thereby
increasing free iron levels. The increased levels of TNF-a with 27-
OHC may also be a cause for the alterations in iron metabolism
and neuronal death, as TNF-a can cause neuronal damage
[75,76]. Inflammation and TNF are known to contribute to the
progression of AD. Interestingly, silencing gadd153 in the slices
with siRNA has reduced the increased levels of TNF-a by 27-
OHC, thus potentially reducing inflammation, oxidative stress and
iron dyshomeostasis.
In summary, we demonstrate that the oxysterol 27-OHC induces
AD-like pathology in organotypic slices from rabbit hippocampus.
Therapeutic strategies for management of AD and other neurolog-
ical disorders characterized by disturbed cholesterol and oxysterol
metabolism have been suggested [77–79]. We also show that ER
stress is an important event induced by the oxysterol 27-OHC.
Interestingly, inhibition of downstream events to ER stress by
silencing gene expression of the growth arrest and DNA-damage-
inducible protein gadd153 markedly protects against 27-OHC-
induced AD-like pathology. Several studies showing increased levels
of 27-OHC in AD brains suggest that increased turn-over of
cholesterol to 27-OHC may contribute to AD pathology. Our study
is of seminal relevance to AD studies in that it adds new information
on the role of gadd153 in underlying Ab production, phosphory-
lated tau accumulation, oxidative stress generation and iron
dyshomeostasis, which all are pathological hallmarks of AD.
Preventing ER stress and silencing gadd153 expression may
represent a strategy to prevent or reduce AD pathology.
Supporting Information
Figure S1 Western blot analyses showing that each of the three
siRNA to gadd153 individually reduces gadd153 as well as
BACE1 levels, thus confirming the specificity of the silencing of
gadd153. *p,0.05, **p,0.01 and ***p,0.001 versus controls.
###p,0.001 versus 27-OHC.
(TIF)
Figure 7. siRNA to gadd153 reduces 27-OHC-induced increase
in TNF-a levels. Western blot (a), densitometric analysis (b), and real-
time RT-PCR (c) showing an increase in TNF-a expression levels with 27-
OHC and a significant decrease in expression levels of TNF-a in slices
treated with siRNA to gadd153. Levels of TNF-a released in media are
also increased with 27-OHC treatment and these levels are reduced by
siRNA to gadd153 (d). Values expressed are mean value 6 SEM from
three different experiments. *p,0.05 and **p,0.01 versus controls;
#p,0.05 and
##p,0.01 versus 27-OHC.
doi:10.1371/journal.pone.0026420.g007
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